The company went public in 2019 at a post-money valuation of $480 million, according to the report. ・InMode has been facing ...

IRVINE, Calif., Oct. 24, 2024 /PRNewswire/ -- InMode Ltd. (INMD), a leading global provider of innovative medical technologies, has been granted a preliminary injunction by the U.S. District Court for ...

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable ...

LAKE FOREST, Calif., Aug. 13, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, is pleased to announce a new FDA clearance to ...

InMode (NASDAQ:INMD) is a promising aesthetic medical product player. Its proprietary radio frequency platform is the focal point of its innovative product offering. However, the company’s financial ...

InMode has a strong competitive position in the rapidly growing global aesthetic market with its innovative products and technology. The company has achieved impressive financial performance with ...

The market for cosmetic surgery-related procedures is worth over $63 billion annually and is growing fast. InMode is gaining a share of the aesthetics market, with proprietary devices and workstations ...

InMode Ltd. INMD is set to report fourth-quarter 2020 results on Feb 10, before market open. In the last reported quarter, the company delivered an earnings surprise of 110%. The company exceeded ...

LAKE FOREST, Calif., Sept. 10, 2019 /PRNewswire/ -- InMode Ltd. (Nasdaq:INMD) ("InMode"), a leading global provider of innovative medical technologies, hosted over 600 physicians and medical ...